HC Wainwright & Co. Maintains Buy on ChromaDex, Raises Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Raghuram Selvaraju has maintained a Buy rating on ChromaDex (NASDAQ:CDXC) and increased the price target from $5 to $6.

March 11, 2024 | 11:23 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on ChromaDex and raises the price target from $5 to $6.
The increase in price target by a reputable analyst firm like HC Wainwright & Co. typically signals a positive outlook on the company's future performance. This endorsement can lead to increased investor confidence and potentially drive up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100